SBRT for limited progression in breast cancer
Part of Cancer, Skin clinical trials.
This trial tests whether focused radiation (SBRT) can treat a few new spots of breast cancer that appear while you are on your first treatment. The goal is to keep your current treatment working longer without needing to switch medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that spread to a few new spots (5 or fewer) while on your first treatment.
- Your cancer was stable for at least 6 months before these new spots appeared.
- You are on hormone therapy plus a CDK4/6 inhibitor (if HR+/HER2-) or a HER2-targeted drug (if HER2+).
- You have not had radiation to the same area before, and the spots are in places that can be treated with focused radiation (SBRT).
- You do not have brain metastases, spinal cord compression, or a condition that makes radiation risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of radiation for people whose cancer has spread to a few new spots while on or after treatment. It tests whether a precise, high-dose radiation approach (stereotactic) works better than the usual palliative radiation for controlling these growing spots.
This trial tests a precise, high-dose radiation treatment (SABR) for people whose cancer has spread to a few spots (up to 5) and is not growing in the brain or been previously treated with radiation in those same spots.
This trial tests whether giving radiation to a few growing spots (1-3) can let you stay on your current drug longer, instead of switching to a new one right away. It's for people with metastatic breast cancer whose disease has been stable for months but now shows limited progression.
This trial looks at adding a focused radiation treatment called SBRT to standard care for cancers that have spread to a limited number of spots. It aims to control those spread-out tumors while still using the usual cancer treatment plan.
This trial compares giving stereotactic ablative radiotherapy as one larger treatment plan versus several smaller plans for people who have only a few cancer spots (or a few spots that are worsening). It may help control metastatic disease while aiming to protect surrounding healthy organs.
This trial tests whether treating just the few spots where breast cancer has spread (called oligometastases) with radiation or surgery can help control the disease. It is for people whose cancer has spread to 3 or fewer places, each small in size, and who are healthy enough for local treatments.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.